| Financial Year |
March 31 2023 |
| Monetary Funds |
490,059,973.62 |
| Held-for-trading Financial Assets |
861,222,603.00 |
| Notes Receivable |
32,749,715.64 |
| Accounts Receivable |
266,689,830.30 |
| Advances to Suppliers |
17,411,098.55 |
| Other Receivables |
4,261,205.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
600,979,573.78 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
24,606,808.59 |
| Total Current Assets |
2,373,885,371.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,155,207,102.36 |
| Under-construction Projects |
4,436,709.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
98,905,938.92 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
14,040,155.66 |
| Other Non-Current Assets |
7,985,137.95 |
| Sub-Total of Non-Current Assets |
1,497,736,849.62 |
| Total Assets |
3,871,622,221.40 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
268,767,803.54 |
| Accounts Payable |
228,601,031.73 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,636,095.87 |
| Taxes Payable |
2,472,155.87 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
11,799,224.28 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
6,352,692.80 |
| Sub-Total of Current Liabilities |
563,834,743.45 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
9,676,421.67 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
81,415,755.13 |
| Total Liabilities |
645,250,498.58 |
| Paid-In Capital(Or Share Stock) |
1,208,190,886.00 |
| Capital Surplus |
1,160,135,086.52 |
| Surplus Reserve |
213,256,275.36 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
586,654,942.28 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,226,371,722.82 |
| Owner's Equity（Stockholder's Equity） |
3,226,371,722.82 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,871,622,221.40 |
